(Q37964515)

26 August 2017

title

Tight blood pressure control in diabetes: evidence-based review of treatment targets in patients with diabetes (English)

1 reference

26 August 2017

1

1 reference

26 August 2017

2

1 reference

26 August 2017

author name string

Valeria Maria Manfreda

series ordinal

3

1 reference

26 August 2017

Fabio Angeli

series ordinal

4

1 reference

26 August 2017

Paolo Verdecchia

series ordinal

5

1 reference

26 August 2017

publication date

1 February 2012

1 reference

Current cardiology reports

26 August 2017

published in

1 reference

26 August 2017

volume

14

1 reference

26 August 2017

issue

1

1 reference

26 August 2017

page(s)

89-96

1 reference

National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2·7 million participants

26 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11886-011-0236-8

Blood pressure lowering for the prevention and treatment of diabetic kidney disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-011-0236-8

Vascular risk factors and diabetic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-011-0236-8

Blood pressure, stroke, and coronary heart disease. Part 1, Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-011-0236-8

Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-011-0236-8

British Hypertension Society guidelines for hypertension management 2004 (BHS-IV): summary

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-011-0236-8

The 2006 Canadian Hypertension Education Program recommendations for the management of hypertension: Part II - Therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-011-0236-8

Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-011-0236-8

Treatment of hypertension in type 2 diabetes mellitus: blood pressure goals, choice of agents, and setting priorities in diabetes care

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-011-0236-8

Tight blood pressure control and cardiovascular outcomes among hypertensive patients with diabetes and coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-011-0236-8

Effects of intensive blood-pressure control in type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-011-0236-8

Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-011-0236-8

Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-011-0236-8

The relation between blood pressure and mortality due to coronary heart disease among men in different parts of the world. Seven Countries Study Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-011-0236-8

Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-011-0236-8

Optimal therapy in hypertensive subjects with diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-011-0236-8

Renal protective effect of enalapril in diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-011-0236-8

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-011-0236-8

Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-011-0236-8

The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-011-0236-8

Renal outcomes in high-risk hypertensive patients treated with an angiotensin-converting enzyme inhibitor or a calcium channel blocker vs a diuretic: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLH

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-011-0236-8

Effect of inhibitors of the renin-angiotensin system and other antihypertensive drugs on renal outcomes: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-011-0236-8

Effects of combination lipid therapy in type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-011-0236-8

Mortality by cause for eight regions of the world: Global Burden of Disease Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-011-0236-8

American Heart Association Prevention Conference. IV. Prevention and Rehabilitation of Stroke. Risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-011-0236-8

Stroke in the diabetic patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-011-0236-8

Long-term risk of first recurrent stroke in the Perth Community Stroke Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-011-0236-8

Association between diabetes and stroke subtype on survival and functional outcome 3 months after stroke: data from the European BIOMED Stroke Project

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-011-0236-8

Diabetes mellitus and risk of Alzheimer's disease and dementia with stroke in a multiethnic cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-011-0236-8

Prognosis after stroke in diabetic patients. A controlled prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-011-0236-8

Economic evidence in stroke: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-011-0236-8

Projected costs of ischemic stroke in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-011-0236-8

Risk factors for myocardial infarction case fatality and stroke case fatality in type 2 diabetes: UKPDS 66.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-011-0236-8

Cumulative meta-analysis of clinical trials builds evidence for exemplary medical care.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-011-0236-8

Cumulating evidence from randomized trials: utilizing sequential monitoring boundaries for cumulative meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-011-0236-8

Relation of reduction in pressure to first myocardial infarction in patients receiving treatment for severe hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-011-0236-8

On-treatment diastolic blood pressure and prognosis in systolic hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-011-0236-8

Relation of low diastolic blood pressure to coronary heart disease death in presence of myocardial infarction: the Framingham Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-011-0236-8

Dogma disputed: can aggressively lowering blood pressure in hypertensive patients with coronary artery disease be dangerous?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-011-0236-8

Prognostic value of blood pressure in patients with high vascular risk in the Ongoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-011-0236-8

Systolic blood pressure, diastolic blood pressure, and pulse pressure: an evaluation of their joint effect on mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-011-0236-8

J-shaped relationship between blood pressure and mortality in hypertensive patients: new insights from a meta-analysis of individual-patient data

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-011-0236-8

Clinical outcomes in the diabetes cohort of the INternational VErapamil SR-Trandolapril study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-011-0236-8

Characteristics and outcomes of revascularized patients with hypertension: an international verapamil SR-trandolapril substudy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-011-0236-8

Outcomes Among hypertensive patients with concomitant peripheral and coronary artery disease: findings from the INternational VErapamil-SR/Trandolapril STudy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-011-0236-8

Effectiveness of Lowering Blood Pressure to Prevent Stroke Versus to Prevent Coronary Events

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-011-0236-8

Upward shift of the lower range of coronary flow autoregulation in hypertensive patients with hypertrophy of the left ventricle

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-011-0236-8

Effect of long-acting nifedipine on mortality and cardiovascular morbidity in patients with symptomatic stable angina and hypertension: the ACTION trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-011-0236-8

Blood pressure change and survival after age 75.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-011-0236-8

The role of therapeutic inertia and the use of fixed-dose combination therapy in the management of hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-011-0236-8

Achieving blood pressure goals globally: five core actions for health-care professionals. A worldwide call to action.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-011-0236-8

Blood pressure targets in subjects with type 2 diabetes mellitus/impaired fasting glucose: observations from traditional and bayesian random-effects meta-analyses of randomized trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-011-0236-8

Blood pressure, lipids and glucose in type 2 diabetes: how low should we go? Re-discovering personalized care

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-011-0236-8

Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS: 23)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-011-0236-8

Exploring the optimal combination therapy in hypertensive patients with diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-011-0236-8

2007 Guidelines for the Management of Arterial Hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-011-0236-8

Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-011-0236-8

ACE-inhibitor use and the long-term risk of renal failure in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-011-0236-8

Effects of intensive blood pressure reduction on myocardial infarction and stroke in diabetes: a meta-analysis in 73 913 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-011-0236-8

Olmesartan for the Delay or Prevention of Microalbuminuria in Type 2 Diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-011-0236-8

Association between blood pressure level and the risk of myocardial infarction, stroke, and total mortality: the cardiovascular health study

21 January 2018

1 reference

12 December 2020

Change in blood pressure and 5-year risk of coronary heart disease among elderly men: the Finnish cohorts of the Seven Countries Study.

1 reference

12 December 2020

Beta-blockers versus diuretics in hypertensive men: main results from the HAPPHY trial

1 reference

12 December 2020

Diastolic Blood Pressure and Mortality in the Elderly With Cardiovascular Disease

1 reference

12 December 2020

Benefits and potential harm of lowering high blood pressure

1 reference

12 December 2020

Cost of stroke in Europe

1 reference

12 December 2020

Randomised trial of treatment of hypertension in elderly patients in primary care

1 reference

12 December 2020

Effect of blood pressure control on diabetic microvascular complications in patients with hypertension and type 2 diabetes

1 reference

12 December 2020

Development of predictive models for long-term cardiovascular risk associated with systolic and diastolic blood pressure

1 reference

12 December 2020

Renoprotection by blocking the RAAS in diabetic nephropathy—fact or fiction?

1 reference

12 December 2020

Effects of different blood pressure-lowering regimens on major cardiovascular events in individuals with and without diabetes mellitus: results of prospectively designed overviews of randomized trials

1 reference

12 December 2020

Level of blood pressure and risk of myocardial infarction among treated hypertensive patients

1 reference

12 December 2020

The CARI guidelines. Prevention of progression of kidney disease

1 reference

12 December 2020

Treatment blood pressure targets for hypertension

1 reference

12 December 2020

Low blood pressure and mortality in the elderly: a 6-year follow-up of 18,022 Norwegian men and women age 65 years and older

1 reference

12 December 2020

Determinants and significance of declining blood pressure in old age. A prospective birth cohort study

1 reference

12 December 2020

The tyranny of power: is there a better way to calculate sample size?

1 reference

12 December 2020

Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group

1 reference

12 December 2020

K/DOQI clinical practice guidelines on hypertension and antihypertensive agents in chronic kidney disease

1 reference

12 December 2020

The J-shaped relationship between coronary heart disease and achieved blood pressure level in treated hypertension: further analyses of 12 years of follow-up of treated hypertensives in the Primary Prevention Trial in Gothenburg, Sweden.

1 reference

12 December 2020

Recovery from stroke in patients with diabetes mellitus

1 reference

12 December 2020

Blood pressure management in diabetes: a path forward?

1 reference

12 December 2020

1 reference

12 December 2020

The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group

1 reference

12 December 2020

10.1007/S11886-011-0236-8

Identifiers

DOI

1 reference

26 August 2017

1 reference